Obesity is the most common metabolic disorder in Westernised countries. The metabolic sequelae of insulin resistance, diabetes mellitus, hypertension and hyperlipidaemia are associated with major morbidity, mortality and health care expenditure. Family studies have identified a genetic component in human obesity, although, as yet, these genetic determinants remain largely unknown [1] .
Summary Disruption of the melanocortin-4 (MC-4) receptor gene in mice results in maturity-onset obesity, hyperinsulinaemia and hyperglycaemia. These phenotypes are characteristic of human obesity that frequently accompanies non-insulin-dependent diabetes. It is therefore possible that human MC-4 receptor gene mutations contribute to human obesity. To test this possibility, we examined by DNA sequencing the entire coding region of the human MC-4 receptor gene in 40 morbidly obese (BMI > 35 kg/ m 2 ) white British males and examined the 5′-and 3′-flanking regions in 20 out of these obese subjects. We also sequenced all these regions in 10 lean (BMI < 18 kg/m 2 ) white British males for a reference. We identified a single nucleotide substitution that replaces valine with isoleucine at codon 103, in two obese subjects in the heterozygous state. No other nucleotide alterations were found. The prevalence of this missense variant was studied in 322 white British males (190 with BMI > 28 kg/m 2 and 132 with BMI < 22 kg/m 2 ) selected from a population-based epidemiological survey. In these subjects, no homozygotes for the isoleucine allele were found. The frequency of heterozygotes was similar (4.2 vs 4.5 %) in the two groups and there was no significant difference in BMI, total skinfold thickness, plasma insulin and glucose levels between heterozygotes and codon-103 valine homozygotes in either group. These results suggest that coding sequence mutations in the MC-4 receptor gene are unlikely to be a major cause of human obesity, at least in white British males. [Diabetologia (1997) targeted disruption of the MC-4 receptor gene in mice results in maturity-onset obesity, hyperinsulinaemia and hyperglycaemia, resembling the agouti obesity syndrome [4] . These observations indicate that the agouti obesity syndrome is caused by chronic antagonism of the MC-4 receptor.
Human obesity is also a maturity-onset disorder associated commonly with metabolic abnormalities such as hyperinsulinaemia and hyperglycaemia. Obese humans commonly have increased plasma levels of leptin [5] , the circulating product of the ob gene, and MC-4 receptor knockout mice also have very high blood levels of leptin [4] . It is therefore possible that genetic defects in MC-4 receptor contribute to obesity in humans. In this study, we determined the DNA sequence of the human MC-4 receptor gene of either extremely obese or lean subjects and examined the significance of an identified missense variant on the development of human obesity and obesity-associated phenotypes.
Subjects and methods
Subjects. White British men aged 40-64 years with both parents born in Britain were selected from the 1988-1990 population-based epidemiological survey of factory workers and Family Practitioner lists in Southall, west London [6] . Of 1262 consecutively sampled white males from the original survey, blood samples were available for DNA extraction from 97 % of the males. In this population the frequency of diabetes was 4.5 % and of impaired glucose tolerance or diabetes 7. 2 ; n = 132), were selected for analysis [6, 7] . In the obese sample 19 subjects (10.1 %) were diabetic and 10 additional subjects (5.3 %) had impaired glucose tolerance. In the lean data set one subject (0.8 %) was diabetic and one additional subject (0.8 %) had impaired glucose tolerance. DNA was also extracted from blood samples of 50 UK resident Asians. The study was approved by the relevant local research ethics committees. Informed written consent was obtained from all study subjects.
Analysis of MC-4 receptor gene.
Human MC-4 receptor is a protein of 332 amino acids encoded by a single exon [8, 9] . Four separate DNA fragments that cover the previously reported 1671 base-pair (bp) genomic sequence [9] encompassing the entire MC-4 receptor coding region were amplified from leukocyte DNA by the polymerase chain reaction (PCR). PCR amplification was performed as described previously [7] with annealing temperature (55°C), MgCl 2 concentration (1.0 mmol/l) and the following PCR primers: Forward (reverse) primer, Fragment 1, 5′-AGCTTCCGAGAGG-CAGCCGA-3′ (GTTCCAGAGGTGCAGAGAAG); 2, AT-CAATTCAGGGGGACACTG (GACAGCACTACTATCT-GAGT); 3, ATGCTCTCCAGTACCATAACA (TGCAGA-AGTACAATATTCAGG); 4, CACTCCGGAGTCAAGA-ACTG (AAGCTTTTAATAAGGACTTTTCT). Fragments 2 and 3 were for analysis of the coding region and Fragments 1 and 4 were for analysis of the 5′-and 3′-flanking regions, respectively. PCR products were sequenced as described previously [7] by cycle-sequencing method.
Analysis of 3′ end of hypothalamic MC-4 receptor mRNA.
The 3′ end of hypothalamic MC-4 receptor mRNA was analysed by rapid amplification of complementary DNA 3′-end (3′-RACE). Briefly, human hypothalamus RNA (1 m g) was pretreated with RNase-free DNase (Promega, Madison, WI, USA) and was reverse-transcribed in 25 m l of reaction mixture as described previously [7] with 0.5 m g of oligo-dT primer attached with an adapter sequence (GACTCGAGTCGACA-TCGATTTTTTTTTTTTTTTTT). One-tenth of the product was amplified by PCR with the forward primer for the Fragment 4 and a 17-mer adapter primer (GACTCGAGTCGA-CATCG).
Genotyping. Genotyping of the DNA sequence variant at codon 103 was carried out by PCR-RFLP analysis. Genomic DNA (50 ng in 25 m l reactions) was amplified by PCR (annealing temperature, 50°C; MgCl 2 concentration, 1.2 mmol/l) with primer A (ATGGAGGGTGCTACGAGCAACT) and primer B (TCTGTACTGTTTAATAGGGTGTTG). Primer B has a sequence mismatch in its 3′-region (underlined) in order to create an artificial restriction site for Hinc II in the PCR products derived from the valine allele. PCR products (7 m l) were digested overnight in a 15 m l reaction mixture with 10 U of Hinc II and were analysed on 4 % (3 : 1 NuSieve : normal, FMC Bioproducts, Rockland, ME, USA) agarose gels.
Statistical analysis. Frequencies of genotypes between obese group (n = 190) and lean group (n = 132) were assessed by chi-square analysis. Differences between groups with different genotypes were assessed by Student's t -test or by multivariate regression analysis including age as a covariate. Total skinfold thickness was defined as the sum of subscapular, suprailiac, anterior thigh, suprapatellar skinfold thickness. Analyses of insulin, glucose and triglycerides used log-transformed values. All statistical analyses were performed using the STATA program (Stata Corp, College Station, TX, USA).
Results
We examined by DNA sequencing the entire coding sequence of the human MC-4 receptor gene, which encodes a G protein-coupled, seven-transmembrane receptor of 332 amino acids [8, 9] , in 40 extremely obese (BMl = 35.1-51.2 kg/m 2 ) and 10 extremely lean (BMl = 16.1-17.8 kg/m 2 ) white British males. In 20 of these obese and 10 of these lean subjects, the DNA sequence of the 5′-and 3′-flanking regions (373 bp and 256 bp in length, respectively, except for primer sequences) [9] were also examined. We found a single base substitution that replaces the published sequence for isoleucine (ATC) [8, 9] with that for valine (GTC) at codon 103 (Fig. 1 A) . Interestingly, the published sequence (ATC) at codon 103 was rare in British subjects, since, in the 50 subjects studied by sequence analysis, 48 were homozygous for the valine (GTC) allele and only two obese subjects were heterozygotes, with no isoleucine-allele (ATC) homozygotes. Codon 169, at which Gantz et al. [8] reported an isoleucine (ATC) sequence and Mountjoy et al. [9] did a serine (AGC) sequence was isoleucine (ATC) in all the 50 British subjects examined. We also found one additional adenine nucleotide in the 3′-flanking region, between nucleotides 1114 (A) and 1115 (T) of the published sequence [9] , in all the 30 British subjects examined. No other sequence difference was found in comparison with previously published data [8, 9] . Results of the 3′-RACE analysis showed that 3′-polyadenylation of human hypothalamic MC-4 receptor mRNA occurred 291 bases downstream of the termination codon (TAA).
The missense gene variation identified at codon 103 (Val103lle) could be detected by analysis of PCR-RFLP (Fig. 1 B) . To examine the possible significance of the Val103lle variation in the general population, we determined the genotype frequency for the Val103lle variation by PCR-RFLP analysis in 322 white British males (190 obese and 132 lean subjects) selected from an epidemiological survey population [6] . No homozygotes for the rare isoleucine allele were found in these 322 subjects. The frequency of heterozygotes was similar in both the obese and lean groups (4.2 vs 4.5 %). In these two groups, there were no significant differences, after Bonferroni correction for multiple tests, in BMI, total skinfold thickness, plasma levels of insulin, glucose and triglycerides (fasting and 2-h OGTT) between heterozygotes and others ( Table 1 ). Considering that the sequence of codon 103 encoded an isoleucine residue in both of the two previous independent reports [8, 9] , it seems likely that the isoleucine allele is much more common in certain populations. We therefore examined the frequency of the Val103lle variation in 50 UK resident Asians for comparison. The frequency was similar to that in British whites: two (4 %) were heterozygotes and the others were homozygotes for the valine allele.
Discussion
Recent results with MC-4 receptor knockout mice and neuropeptide Y (NPY) knockout mice, combined with the results with agonists and antagonists of hypothalamic melanocortin receptors, have suggested a novel framework for the system that regulates body weight [10] . The framework assumes the physiological responses to starvation (weight loss) as being distinct from the responses to obesity (weight gain): the former responses are triggered by decrease in leptin levels and mediated by hypothalamic NPY, whereas the latter responses are triggered by increase in leptin levels and mediated via hypothalamic MC-4 receptor pathways [10] . Human obesity is characterised by increased blood leptin levels or apparent "leptin resistance" [5] , compatible with the disruption of the responses to weight gain, especially downstream of leptin production. This is exemplified by defects in the leptin receptor in db mice. However, to date, no such functionally defective mutations have been identified in the human leptin receptor gene [5, 7] . Abnormalities in the MC-4 receptor pathway may therefore contribute to development of human obesity. In the present study, we have identified a missense gene variation of the human MC-4 receptor through examination of the entire coding region of the human MC-4 receptor gene in 40 extremely obese or 10 extremely lean white British males. The only gene variation identified at codon 103 was not associated with human obesity or obesity-related phenotypes, although homozygotes for the isoleucine allele were not available for analysis because no homozygotes were found in either of the two populations examined. In 20 extremely obese and 10 extremely lean white British males, the 5′-and 3′-flanking sequences available with known information [9] were also examined. The sequenced 3′-flanking region (256 bp) was shown to correspond to most of the 3′-untranslated region (291 bases) of MC-4 receptor mRNA, but no mutations were found. Taken together, these results suggest that coding sequence mutations in the MC-4 receptor gene are not a major cause of human obesity, at least in white British males. However, this does not exclude coding sequence mutations in women, in other populations or in rare pedigrees, or mutations in further flanking regions as a cause of obesity. Exclusion of these possibilities must await further analysis of the unknown flanking sequence of the human MC-4 receptor gene (especially the 5′-promoter region) and linkage studies with flanking markers close to the human MC-4 receptor gene locus on chromosome 18 q21.3 [8] . Values are means ± SEM. P -values were determined by Student's t-test
